Abiraterone Tablet, Film Coated
Product Images NDC 72205-285

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone (NDC 72205-285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250-mg-120s (Abiraterone 250mg 120s Container Label)

Abiraterone Acetate Tablets USP 250 mg film-coated oral tablets label. The label states prescription use, contains 120 tablets, and includes a warning for women who are or may be pregnant. Manufactured by MSN Laboratories Private Limited and distributed by Novadoz Pharmaceuticals LLC. Storage instructions and dosing details reference the package insert.*

FDA Label Image

Figure-01 (Abiraterone Figure 01)

A survival curve chart comparing Abiraterone and Placebo over time, showing percentage survival on the vertical axis and time to death in months on the horizontal axis, with a legend indicating which line corresponds to each treatment group.*

FDA Label Image

Figure-02 (Abiraterone Figure 02)

A Kaplan-Meier survival curve chart depicting the percentage of subjects without death over time in months from randomization, comparing Abiraterone and Placebo groups. The x-axis shows months from 0 to 60, and the y-axis shows percent of subjects without death from 0 to 100%. Two curves represent survival for Abiraterone and Placebo groups respectively.*

FDA Label Image

Figure-03 (Abiraterone Figure 03)

This is a Kaplan-Meier survival curve comparing the percentage of subjects without radiographic progression or death over time for Abiraterone and placebo groups. The x-axis shows months from randomization up to 18 months, and the y-axis indicates the percentage of subjects without progression or death. The solid line represents Abiraterone, and the dashed line represents placebo, showing a divergence in survival outcomes between the two groups over the study period.*

FDA Label Image

Abiraterone-structure (Abiraterone Structure)

Chemical structure of abiraterone acetate, the active ingredient in Abiraterone tablets. The diagram shows the molecular structure including rings and functional groups characteristic of abiraterone acetate.*

FDA Label Image

Figure 4

A Kaplan-Meier survival curve chart showing the percentage survival of subjects without death over months from randomization. The chart compares two groups: Abiraterone and Placebo, depicting that the Abiraterone group has a consistently higher survival rate over time. The chart includes a table of numbers of subjects at risk at various time points for each group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.